Phase I Study of Bryostatin 1 (NSC 339555) and Fludarabine in Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2010
At a glance
- Drugs Bryostatin-1 (Primary) ; Fludarabine (Primary)
- Indications Chronic lymphocytic leukaemia; Hairy cell leukaemia; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 02 Mar 2010 Actual patient number (54) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual end date (August 2006) added as reported by ClinicalTrials.gov.
- 22 Aug 2006 Status change